Mehdi Razavi, MD

Dr. Razavi is involved with numerous clinical trials assessing the efficacy of cutting edge technology in the field of cardiac electrophysiology. His innovations have been featured in Scientific American, InnovationMap, Voice of America News, and Texas Heart Institute News. In addition, he develops, oversees, and executes long-term collaborations with engineering colleagues at Texas Heart Institute’s Cardiovascular Research Laboratory and with exceptional collaborators at Rice University, the University of Houston, Texas A&M University, and UCLA. Show full bio

Dr. Razavi has founded multiple medical device startups for the treatment of arrhythmia and other cardiovascular conditions. Additionally, Dr. Razavi has supervised the development of a number of technologies in collaboration with Rice University and Texas A&M and has 18 patents to his name.

See Publications

Education

  • Medical School:

    Medical College Of Pennsylvania

  • Residency:

    Mayo Graduate School of Medicine

  • Fellowships:

    Mayo Graduate School of Medicine

Academic & Clinical Affiliations

  • Baylor College of Medicine
  • Rice University
  • Baylor St. Luke's Medical Center
  • Hall-Garcia Cardiology at Baylor College of Medicine

Certifications

  • American Board of Internal Medicine, Cardiology (2001, 2011)
  • American Board of Internal Medicine, Clinical Cardiology Electrophysiology (2002, 2012)

Honors, Awards and Memberships

  • Robert J. Hall Outstanding Cardiology Faculty Teaching Award (2006, 2013)
  • Texas Heart Institute EP Teaching Attending of the Year 2019
  • Texas Heart Institute Professional Staff
  • Pfizer Award for Excellence in Electrophysiology Training from the North American Society of Pacing and Electrophysiology (NASPE; now the Heart Rhythm Society)

Publications

Recent News

The Heart Beat: Technology aimed to protect against ventilator-induced diaphragmatic dysfunction (VIDD)

In Ep 13 of The Heart Beat, host Maya Pomroy explores a condition called ventilator-induced diaphragmatic dysfunction (VIDD) that can...

New Technology Could Mitigate Post-Operative Atrial Fibrillation

A preclinical research study from the Texas Heart Institute further validated a new technology developed by NativeCardio designed to mitigate postoperative atrial fibrillation (POAF): a critical...

Scientific Papers Take Our Research to the World

Since its creation in 1962, Texas Heart Institute has been a leader in advancing cardiovascular medicine, making discoveries that have...